Our national network not only allows us to play a unique role, it compels us to do so. Responsible for the care of approximately 15% of all newly diagnosed US cancer patients, US Oncology is obligated to help patients access the information they need to make rational decisions about care and care-related public policy initiatives.

Therefore, we serve as a resource for patient advocacy groups, help those on the frontlines of patient care reform, and communicate with patients on issues relating to treatment choices and rights.

For more information on patient advocacy activities within the US Oncology network, or how you can contribute to this effort, please visit our LegisLink Action Center, or e-mail Matt Brow, National Director of Government Relations and Public Policy for US Oncology.